Page last updated: 2024-12-05

diethyl pyrocarbonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Diethyl Pyrocarbonate: Preservative for wines, soft drinks, and fruit juices and a gentle esterifying agent. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

diethyl pyrocarbonate : The diethyl ester of dicarbonic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3051
CHEMBL ID55517
CHEBI ID59051
SCHEMBL ID15582
MeSH IDM0006345

Synonyms (77)

Synonym
pyrokohlensaeure diaethyl ester
pyrocarbonate d'ethyle
lmr3lzg146 ,
4-03-00-00018 (beilstein handbook reference)
unii-lmr3lzg146
dicarbonic acid, 1,3-diethyl ester
diethylpyrokarbonat
diethylester kyseliny diuhlicite
bdbm50035000
pyrocarbonate d''ethyle
ethoxycarbonyl ethyl carbonate
diethylpyrocarbonate ,
depc
diethyldicarbonate
einecs 216-542-8
ethyl pyrocarbonate
diethyl ester of pyrocarbonic acid
diethyl pyrocarbonic acid
dicarbonic acid diethyl ester
formic acid, oxydi-, diethyl ester
ccris 4920
brn 0637031
ethoxyformic acid anhydride
piref
pyrocarbonate d'ethyle [french]
baycovin
pyrocarbonic acid, diethyl ester
diethylpyrokarbonat [czech]
diethylester kyseliny diuhlicite [czech]
dkd ,
pyrocarbonic acid diethyl ester
oxydiformic acid diethyl ester
dicarbonic acid, diethyl ester
pyrokohlensaeure diaethyl ester [german]
diethyl oxydiformate
pyrocarbonate, diethyl
oxydiformate, diethyl
anhydride, ethoxyformic
dicarbonate, diethyl
inchi=1/c6h10o5/c1-3-9-5(7)11-6(8)10-4-2/h3-4h2,1-2h
diethyl dicarbonate
carbonic acid,ethyl ester,anhydride
carbonic acid, ethoxycarbonyl ethyl ester
1609-47-8
diethyl pyrocarbonate
diethyl pyrocarbonate, >=97% (nmr)
diethyl pyrocarbonate, 99% (nt)
diethyl pyrocarbonate, 97%
CHEMBL55517 ,
chebi:59051 ,
FT-0657552
A810205
AKOS015900388
diethyl pyrocarbonate [mi]
ue-5908
dicarbonic acid c,c'-diethyl ester
SCHEMBL15582
dtxsid2051764 ,
tox21_303976
dtxcid1030319
cas-1609-47-8
NCGC00357200-01
mfcd00009106
J-200332
3,3',5,5'-tetraethylbenzidine
diethyl pyrocarbonate, purum, >=97.0% (nt)
H11295
diethyl pyrocarbonate, vetec(tm) reagent grade, >=97%
dicarbonic acid, c,c'-diethyl ester
Q421385
AS-10585
diethyl-pyrocarbonate
depc (diethylpyrocarbonate)
diethylpyrocarbonate hi-pu grade 100g
EN300-84341
HY-D0846
CS-0014816

Research Excerpts

Overview

Diethyl pyrocarbonate (DEP) is an electrophilic reagent. It is used to modify reversibly the histidine residues of proteins.

ExcerptReferenceRelevance
"Diethyl pyrocarbonate (DEP) is an electrophilic reagent that is used to modify reversibly the histidine residues of proteins. "( Identification by proton nuclear magnetic resonance of the histidines in cytochrome b5 modified by diethyl pyrocarbonate.
Altman, J; Kuntz, I; Lipka, JJ; Waskell, L, 1989
)
1.94

Effects

Diethyl pyrocarbonate (DEPC) has been used as a residue-specific modifying agent to study the role of His residues in peptide/protein and enzyme function. Its action is not specific, and several other residues can also be modified.

ExcerptReferenceRelevance
"Diethyl pyrocarbonate (DEPC) has been primarily used as a residue-specific modifying agent to study the role of His residues in peptide/protein and enzyme function; however, its action is not specific, and several other residues can also be modified. "( Copper(II) partially protects three histidine residues and the N-terminus of amyloid-β peptide from diethyl pyrocarbonate (DEPC) modification.
Friedemann, M; Palumaa, P; Tõugu, V, 2020
)
2.22
"Diethyl pyrocarbonate (DEPC) has been useful in vitro as an agent relatively specific for binding to imidazole of histidine. "( Diethyl pyrocarbonate (an imidazole binding substance) inhibits rostral VLM CO2 sensitivity.
Nattie, EE, 1986
)
3.16
"Diethyl pyrocarbonate has proved a sensitive structural probe for the analysis, with single nucleotide resolution, of DNA cruciform structures."( Diethyl pyrocarbonate: a chemical probe for DNA cruciforms.
Nordheim, A; Scholten, PM, 1986
)
2.44

Treatment

Diethyl pyrocarbonate (DEPC) inhibits reduction of the cytochrome by ascorbate. This activity can be restored by subsequent treatment with hydroxylamine, suggesting the involvement of an essential histidine residue. Treatment with DEPC inactivated recombinant human QC with the apparent modification of three essentialhistidine residues.

ExcerptReferenceRelevance
"Diethyl pyrocarbonate treatment produced a dose-related inhibition of specific [3H]diazepam binding to rat brain membranes with a maximal inhibition of approximately 40% at 1 mM."( Histidine modification with diethyl pyrocarbonate shows heterogeneity of benzodiazepine receptors.
Burch, TP; Ticku, MK, 1981
)
1.28
"3. Diethyl pyrocarbonate (DEPC; 10 mM) treatment of P2X4-injected oocytes had no effect on the pH sensitivity of the ATP-activated current."( Mutation of histidine 286 of the human P2X4 purinoceptor removes extracellular pH sensitivity.
Benham, CD; Bridges, A; Clarke, CE; George, AR; Meadows, HJ, 2000
)
0.82
"Diethyl pyrocarbonate treatment inactivated DXP reductoisomerase, and subsequent hydroxylamine treatment restored the activity of the diethyl pyrocarbonate-treated enzyme."( Characterization of 1-deoxy-D-xylulose 5-phosphate reductoisomerase, an enzyme involved in isopentenyl diphosphate biosynthesis, and identification of its catalytic amino acid residues.
Kuzuyama, T; Seto, H; Takagi, M; Takahashi, S, 2000
)
1.03
"Treatment with diethyl pyrocarbonate (DEPC) inhibits reduction of the cytochrome by ascorbate, but this activity can be restored by subsequent treatment with hydroxylamine, suggesting the involvement of an essential histidine residue."( Evidence for an essential histidine residue in the ascorbate-binding site of cytochrome b561.
Kelley, PM; Kipp, BH; Njus, D, 2001
)
0.65
"Treatment with diethyl pyrocarbonate inactivated recombinant human QC with the apparent modification of three essential histidine residues."( Evidence for essential histidines in human pituitary glutaminyl cyclase.
Bateman, RC; Booth, RE; Misquitta, SA; Temple, JS, 2001
)
0.65

Bioavailability

ExcerptReferenceRelevance
" The relative bioavailability of ibuprofen and naproxen, following oral administration of ibudice and napdice, was 96% and 74%, respectively, and the rate of absorption was not significantly different from that obtained following oral dosing of the parent compound."( Pharmacokinetic analysis of diethylcarbonate prodrugs of ibuprofen and naproxen.
Avnir, D; Bialer, M; Ladkani, D; Samara, E, 1995
)
0.29

Dosage Studied

ExcerptRelevanceReference
" (1) The dose-response relation does not correspond to action at a single site."( Zinc inhibition of potassium efflux in depolarized frog muscle and its modification by external hydrogen ions and diethylpyrocarbonate treatment.
Horowicz, P; Spalding, BC; Swift, JG, 1986
)
0.27
" Fat cells treated with diethyl pyrocarbonate exhibit a rightward shift in the dose-response relationship for insulin-stimulated glucose oxidation consistent with a loss in receptor number due to the reagent."( Modification of the insulin receptor by diethyl pyrocarbonate: effect on insulin binding and action.
Pilch, PF, 1982
)
0.84
" The relative bioavailability of ibuprofen and naproxen, following oral administration of ibudice and napdice, was 96% and 74%, respectively, and the rate of absorption was not significantly different from that obtained following oral dosing of the parent compound."( Pharmacokinetic analysis of diethylcarbonate prodrugs of ibuprofen and naproxen.
Avnir, D; Bialer, M; Ladkani, D; Samara, E, 1995
)
0.29
" PCMBS inhibited F uptake by up to 83% in a dose-response manner."( pH-dependent fluoride transport in intestinal brush border membrane vesicles.
Ganapathy, V; He, H; Isales, CM; Whitford, GM, 1998
)
0.3
" Results indicate that these dose-response plots are much more reliable and generally applicable probes of possible protein structural changes than fluorescence or circular dichroism spectroscopies."( Protein surface mapping using diethylpyrocarbonate with mass spectrometric detection.
Mendoza, VL; Vachet, RW, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
acyclic carboxylic anhydride
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (60)

PathwayProteinsCompounds
betacyanin biosynthesis117
quercetin gentiotetraside biosynthesis317
kaempferol gentiobioside biosynthesis317
superpathway of anthocyanin biosynthesis (from pelargonidin 3-O-glucoside)231
superpathway of hyoscyamine and scopolamine biosynthesis434
salvianin biosynthesis121
hyoscyamine and scopolamine biosynthesis422
shisonin biosynthesis117
pelargonidin conjugates biosynthesis223
superpathway of betalain biosynthesis241
flavonol glucosylation I118
myricetin gentiobioside biosynthesis316
lupanine biosynthesis017
superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside)519
vicianin bioactivation113
superpathway of anaerobic sucrose degradation3360
sucrose degradation II (sucrose synthase)1722
myricetin gentiobioside biosynthesis317
chitin biosynthesis1640
allantoin degradation to ureidoglycolate II (ammonia producing)518
allantoin degradation to glyoxylate III421
O-antigen building blocks biosynthesis (E. coli)950
N-acetylneuraminate and N-acetylmannosamine degradation I416
superpathway of b heme biosynthesis from glycine1046
superpathway of L-phenylalanine biosynthesis1665
L-glutamate degradation II223
superpathway of N-acetylglucosamine, N-acetylmannosamine and N-acetylneuraminate degradation924
patulin biosynthesis532
trehalose degradation II (cytosolic)621
acetate and ATP formation from acetyl-CoA I1223
anaerobic energy metabolism (invertebrates, mitochondrial)1342
superpathway of anaerobic energy metabolism (invertebrates)1660
superpathway of demethylmenaquinol-8 biosynthesis I1133
superpathway of N-acetylneuraminate degradation3979
u03B2-(1,4)-mannan degradation515
superpathway of L-methionine biosynthesis (transsulfuration)959
superpathway of L-homoserine and L-methionine biosynthesis649
L-methionine biosynthesis I430
superpathway of hexitol degradation (bacteria)2960
mannitol cycle315
D-sorbitol degradation II210
UDP-N-acetyl-D-glucosamine biosynthesis I735
lupanine biosynthesis019
superpathway of L-lysine, L-threonine and L-methionine biosynthesis I1994
superpathway of L-aspartate and L-asparagine biosynthesis730
superpathway of aromatic amino acid biosynthesis2184
chorismate biosynthesis I1559
chorismate biosynthesis from 3-dehydroquinate1037
CMP-3-deoxy-D-manno-octulosonate biosynthesis822
sucrose degradation II (sucrose synthase)1320
superpathway of bacteriochlorophyll a biosynthesis2270
2-carboxy-1,4-naphthoquinol biosynthesis2129
superpathway of L-tyrosine biosynthesis1557
superpathway of menaquinol-8 biosynthesis I1036
superpathway of hyoscyamine and scopolamine biosynthesis441
superpathway of chorismate metabolism56186
gallate degradation III (anaerobic)130
aspartate superpathway25122
betacyanin biosynthesis124
superpathway of betalain biosynthesis252
superpathway of S-adenosyl-L-methionine biosynthesis961
salvianin biosynthesis122
superpathway of L-tryptophan biosynthesis1665
pelargonidin conjugates biosynthesis225
superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside)424
shisonin biosynthesis120
superpathway of anthocyanin biosynthesis (from pelargonidin 3-O-glucoside)233
superpathway of anaerobic sucrose degradation2661
superpathway of UDP-N-acetylglucosamine-derived O-antigen building blocks biosynthesis2461
tetrapyrrole biosynthesis II (from glycine)730
methanogenesis from acetate526
gallate biosynthesis213
hyoscyamine and scopolamine biosynthesis423
quercetin gentiotetraside biosynthesis319

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency2.73060.001530.607315,848.9004AID1224841
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sterol O-acyltransferase 2Homo sapiens (human)IC50 (µMol)170.00000.11003.20369.2000AID1342231
Sterol O-acyltransferase 1Homo sapiens (human)IC50 (µMol)44.00000.02501.79758.0000AID1342230
Retinal dehydrogenase 1 Rattus norvegicus (Norway rat)IC50 (µMol)740.00002.50002.50002.5000AID34027
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (9)

Processvia Protein(s)Taxonomy
cholesterol metabolic processSterol O-acyltransferase 2Homo sapiens (human)
macrophage derived foam cell differentiationSterol O-acyltransferase 2Homo sapiens (human)
cholesterol storageSterol O-acyltransferase 2Homo sapiens (human)
intestinal cholesterol absorptionSterol O-acyltransferase 2Homo sapiens (human)
cholesterol effluxSterol O-acyltransferase 2Homo sapiens (human)
very-low-density lipoprotein particle assemblySterol O-acyltransferase 2Homo sapiens (human)
low-density lipoprotein particle clearanceSterol O-acyltransferase 2Homo sapiens (human)
cholesterol homeostasisSterol O-acyltransferase 2Homo sapiens (human)
cholesterol metabolic processSterol O-acyltransferase 1Homo sapiens (human)
cholesterol metabolic processSterol O-acyltransferase 1Homo sapiens (human)
macrophage derived foam cell differentiationSterol O-acyltransferase 1Homo sapiens (human)
cholesterol storageSterol O-acyltransferase 1Homo sapiens (human)
cholesterol effluxSterol O-acyltransferase 1Homo sapiens (human)
very-low-density lipoprotein particle assemblySterol O-acyltransferase 1Homo sapiens (human)
low-density lipoprotein particle clearanceSterol O-acyltransferase 1Homo sapiens (human)
cholesterol homeostasisSterol O-acyltransferase 1Homo sapiens (human)
positive regulation of amyloid precursor protein biosynthetic processSterol O-acyltransferase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
fatty-acyl-CoA bindingSterol O-acyltransferase 2Homo sapiens (human)
sterol O-acyltransferase activitySterol O-acyltransferase 2Homo sapiens (human)
protein bindingSterol O-acyltransferase 2Homo sapiens (human)
cholesterol bindingSterol O-acyltransferase 2Homo sapiens (human)
acyltransferase activitySterol O-acyltransferase 2Homo sapiens (human)
cholesterol O-acyltransferase activitySterol O-acyltransferase 2Homo sapiens (human)
fatty-acyl-CoA bindingSterol O-acyltransferase 1Homo sapiens (human)
sterol O-acyltransferase activitySterol O-acyltransferase 1Homo sapiens (human)
protein bindingSterol O-acyltransferase 1Homo sapiens (human)
cholesterol bindingSterol O-acyltransferase 1Homo sapiens (human)
cholesterol O-acyltransferase activitySterol O-acyltransferase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
endoplasmic reticulumSterol O-acyltransferase 2Homo sapiens (human)
endoplasmic reticulum membraneSterol O-acyltransferase 2Homo sapiens (human)
brush borderSterol O-acyltransferase 2Homo sapiens (human)
endoplasmic reticulum membraneSterol O-acyltransferase 2Homo sapiens (human)
endoplasmic reticulumSterol O-acyltransferase 1Homo sapiens (human)
endoplasmic reticulum membraneSterol O-acyltransferase 1Homo sapiens (human)
membraneSterol O-acyltransferase 1Homo sapiens (human)
endoplasmic reticulum membraneSterol O-acyltransferase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID34027In vitro inhibition against yeast Alcohol dehydrogenase1995Journal of medicinal chemistry, May-26, Volume: 38, Issue:11
Carbethoxylating agents as inhibitors of aldehyde dehydrogenase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,108)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990416 (37.55)18.7374
1990's459 (41.43)18.2507
2000's158 (14.26)29.6817
2010's59 (5.32)24.3611
2020's16 (1.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.97 (24.57)
Research Supply Index7.03 (2.92)
Research Growth Index4.33 (4.65)
Search Engine Demand Index78.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (0.27%)5.53%
Reviews11 (0.98%)6.00%
Case Studies1 (0.09%)4.05%
Observational0 (0.00%)0.25%
Other1,110 (98.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]